Expert: Blaming Greenpeace for blocking Golden Rice is “sleazy sleight of hand”
By Claire Robinson and Jonathan Matthews,
GMWatch
| 06. 02. 2024
With the recent Philippines court decision blocking the further planting of GM Golden Rice in the country, pro-GMO advocates have renewed their attacks on Greenpeace, which, with the farmer-scientist network MASIPAG and others, brought the lawsuit.
The Observer’s science editor Robin McKie has published an article accusing Greenpeace of causing “a catastrophe” by its role in the court case. GM Golden Rice is engineered to contain the vitamin A precursor beta-carotene and is targeted at poor people, especially children, suffering from vitamin A deficiency (VAD).
The Observer also chimed in with an editorial headlined, “When modified rice could save thousands of lives, it is wrong to oppose it”, and subtitled, “The green movement’s attempts to block the cultivation of a grain enhanced with vitamin A is misguided”.
However, experts on Golden Rice have roundly debunked the claims, with one pointing out that blaming Greenpeace for blocking the GM crop is “a sleazy sleight of hand to hide the fact that after 30 years of development, Golden Rice is still not ready”. Glenn Davis Stone, Research Professor of Environmental Science at Sweet...
Related Articles
By Rob Stein, NPR | 12.13.2024
Lucy Landman was born with a very rare genetic disorder that causes severe intellectual disability, weak muscles and seizures, among other symptoms.
"She is expected to very much never be able to live independently, likely never be potty trained...
By Kristine Servando, Bloomberg | 12.05.2024
(Bloomberg) — A woman in Hong Kong had to travel to two different countries to attempt conceiving a baby on her own. A gay couple in the city resorted to even bigger extremes: Banned from surrogacy, they turned to the...
By Stefan Bernhardt-Radu, Aeon | 12.02.2024
In the 18th century, European scholars began to envision a more enlightened world in harmony with nature. The old aristocratic regime, some hoped, would soon be replaced by a progressive society in which moral and social values were aligned with...
By Staff, Reuters | 12.04.2024
The Centers for Medicare & Medicaid Services said on Wednesday it had entered into agreements with Vertex Pharmaceuticals (VRTX.O), opens new tab and bluebird bio (BLUE.O), opens new tab to help increase patient access to their gene therapies.
The so-called...